https://www.dovepress.com/review-of-advanced-drug-trials-focusing-on-the-reduction-of-brain-beta-peer-reviewed-fulltext-article-JEP
Current therapeutic interventions in phase II/III of clinical development or higher that are capable of reducing abnormal brain Aβ levels.
Create an account or login to join the discussion